BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23106243)

  • 1. Can we use a lower intravaginal dose of misoprostol in the medical management of miscarriage? A randomised controlled study.
    Petersen SG; Perkins A; Gibbons K; Bertolone J; Devenish-Meares P; Cave D; Mahomed K
    Aust N Z J Obstet Gynaecol; 2013 Feb; 53(1):64-73. PubMed ID: 23106243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of missed miscarriage in an outpatient setting: 800 versus 600 μg of vaginal misoprostol.
    Barceló F; De Paco C; López-Espín JJ; Silva Y; Abad L; Parrilla JJ
    Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):39-43. PubMed ID: 22145604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage.
    Bagratee JS; Khullar V; Regan L; Moodley J; Kagoro H
    Hum Reprod; 2004 Feb; 19(2):266-71. PubMed ID: 14747165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised double blind trial comparing misoprostol or placebo in the management of early miscarriage.
    Blohm F; Fridén BE; Milsom I; Platz-Christensen JJ; Nielsen S
    BJOG; 2005 Aug; 112(8):1090-5. PubMed ID: 16045523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial to compare the use of sublingual misoprostol with or without an additional 1 week course for the management of first trimester silent miscarriage.
    Tang OS; Ong CY; Tse KY; Ng EH; Lee SW; Ho PC
    Hum Reprod; 2006 Jan; 21(1):189-92. PubMed ID: 16155071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous administration of mifepristone and misoprostol for early termination of pregnancy: a randomized controlled trial.
    Goel A; Mittal S; Taneja BK; Singal N; Attri S
    Arch Gynecol Obstet; 2011 Jun; 283(6):1409-13. PubMed ID: 21431329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose misoprostol used in outpatient management of first trimester spontaneous abortion.
    Sifakis S; Angelakis E; Vardaki E; Fragouli Y; Koumantakis E
    Arch Gynecol Obstet; 2005 Sep; 272(3):183-6. PubMed ID: 15909189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A medical approach to management of spontaneous abortion using misoprostol. Extending misoprostol treatment to a maximum of 48 hours can further improve evacuation of retained products of conception in spontaneous abortion.
    Chung T; Leung P; Cheung LP; Haines C; Chang AM
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):248-51. PubMed ID: 9093140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expectant, medical, or surgical management of first-trimester miscarriage: a meta-analysis.
    Sotiriadis A; Makrydimas G; Papatheodorou S; Ioannidis JP
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1104-13. PubMed ID: 15863551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual versus vaginal misoprostol for the management of missed abortion.
    Tanha FD; Feizi M; Shariat M
    J Obstet Gynaecol Res; 2010 Jun; 36(3):525-32. PubMed ID: 20598032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study between oral and sublingual 600 µg misoprostol for the treatment of incomplete abortion.
    Paritakul P; Phupong V
    J Obstet Gynaecol Res; 2010 Oct; 36(5):978-83. PubMed ID: 20846257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriages.
    Tang OS; Lau WN; Ng EH; Lee SW; Ho PC
    Hum Reprod; 2003 Jan; 18(1):176-81. PubMed ID: 12525463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: a randomised trial.
    Caliskan E; Doger E; Cakiroglu Y; Corakci A; Yucesoy I
    Eur J Contracept Reprod Health Care; 2009 Feb; 14(1):55-60. PubMed ID: 19241302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two routes of administration for misoprostol in the treatment of incomplete abortion: a randomized clinical trial.
    Diop A; Raghavan S; Rakotovao JP; Comendant R; Blumenthal PD; Winikoff B
    Contraception; 2009 Jun; 79(6):456-62. PubMed ID: 19442782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol treatment vs expectant management in women with early non-viable pregnancy and vaginal bleeding: a pragmatic randomized controlled trial.
    Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):24-32. PubMed ID: 29072372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient versus inpatient intravaginal misoprostol for the treatment of first trimester incomplete miscarriage: a randomised controlled trial.
    Ng BK; Annamalai R; Lim PS; Aqmar Suraya S; Nur Azurah AG; Muhammad Abdul Jamil MY
    Arch Gynecol Obstet; 2015 Jan; 291(1):105-13. PubMed ID: 25078052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient medical management of missed miscarriage using misoprostol.
    Shankar M; Economides DL; Sabin CA; Tan B; Kadir RA
    J Obstet Gynaecol; 2007 Apr; 27(3):283-6. PubMed ID: 17464813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of complete miscarriage after expectant management or misoprostol treatment of non-viable early pregnancy in women with vaginal bleeding.
    Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
    Arch Gynecol Obstet; 2020 Nov; 302(5):1279-1296. PubMed ID: 32638095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.